mutant genes

(St. Jude Children's Research Hospital) A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia that have a high risk of relapse and death.

The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.